US Stock MarketDetailed Quotes

LIPO Lipella Pharmaceuticals

Watchlist
  • 2.610
  • +0.040+1.56%
Close Dec 20 16:00 ET
  • 2.660
  • +0.050+1.92%
Post 20:01 ET
3.16MMarket Cap-0.61P/E (TTM)

About Lipella Pharmaceuticals Company

Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.

Company Profile

SymbolLIPO
Company NameLipella Pharmaceuticals
Listing DateDec 20, 2022
Founded2005
CEODr. Jonathan Kaufman, M.B.A.,PhD
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address7800 Susquehanna Street,Suite 505
CityPittsburgh
ProvincePennsylvania
CountryUnited States of America
Zip Code15208
Phone1-412-901-0315
Websitehttp://www.lipella.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jonathan Kaufman, M.B.A.,PhD
  • Chairman of the Board, President, Chief Executive Officer, Secretary and Treasurer
  • 323.38K
  • Douglas Johnston, C.P.A.
  • Chief Financial Officer
  • 260.00K
  • Dr. Michael Chancellor, M.D.
  • Chief Medical Officer and Director
  • 315.08K
  • Ryan Pruchnic, M.B.A.
  • Independent Director
  • 62.50K
  • Dr. Naoki Yoshimura, M.D.,PhD
  • Independent Director
  • 62.50K
  • Dr. Byong Kim, PhD
  • Independent Director
  • 63.30K
  • Daniel R. Cohen, M.B.A.
  • Independent Director
  • 63.63K
  • Dr. Lori Birder, PhD
  • Independent Director
  • 12.50K
Heat List
US
Overall
Symbol
Price
% Chg

No Data